
Myeloma 2017 day 2 highlights: MRD, targeted therapies and imaging advances
VJHemOnc Podcast
Advancements in Targeted Therapies and Imaging for Myeloma
This chapter explores the exciting progress in targeted therapies for myeloma, including the use of vanetta clacks to target the BCL2 protein and the potential of next-generation molecules like MCL1. It also discusses the importance of intelligent drug combinations and the development of new imaging technologies for improved disease monitoring.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.